Navigation Links
International research collaboration narrows focus on genetic cause of Kawasaki disease
Date:12/17/2007

Researchers from Japans RIKEN SNP Research Center, collaborating with a team at the University of California, San Diego (UCSD), have discovered a new genetic variation that affects a childs risk of getting Kawasaki disease (KD), an illness characterized by acute inflammation of the arteries throughout the body. The genetic variation influences immune activation and the response to standard treatment, as well as the risk of developing coronary artery aneurysms a swelling of the artery that can result in blood clots and heart attack as a complication of KD.

Lead author, Yoshi Onouchi, M.D., Ph.D., SNP Research Center, RIKEN, Yokohama, Japan, used DNA from hundreds of U.S. children and their parents, collected through the Kawasaki Disease Research Center at Rady Childrens Hospital San Diego (RCHSD), Department of Pediatrics, UCSD School of Medicine.

This was a wonderful collaboration, said co-author, Jane Burns, M.D., professor and chief, Division of Allergy, Immunology, and Rheumatology, UCSD Department of Pediatrics. Dr. Onouchi used our DNA to make this observation. Now we are building on that observation.

Kawasaki Disease, a pediatric illness characterized by fever and rash, is not a rare illness but it is most prevalent in Japan. In San Diego County, 20 to 30 children per 100,000 children less than five years of age are affected each year. More than 50 new patients are treated annually at RCHSD. The illness is four to five times more common than some more publicly recognized diseases of children such as tuberculosis or bacterial meningitis.

If untreated, KD can lead to lethal coronary artery aneurysms. KD tends to run in families, suggesting that there are genetic components to disease risk. It is also 10 to 20 times more common in Japanese and Japanese American children than in children of European descent.

Researchers identified a region on chromosome 19 linked with the disease. In particular, a ser
'/>"/>

Contact: Kimberly Edwards
kedwards@ucsd.edu
619-543-6163
University of California - San Diego
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. International study strengthens case for daily calcium pill
2. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
3. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
4. LCA Hails International Investigators Studying Lung Cancer
5. Arrow International Urges Shareholders To Vote for Approval of the $45.50 Teleflex Inc. Merger and for the Current Board of Directors
6. PRA International Adds Dr. Susan Stansfield as Executive Vice President
7. Medical Services International Maintains Pace in Second Quarter
8. Clarity Imaging International, Inc. Rolls Out Mobile DEXA Program
9. International Gateway Insurance Brokers Partners With MEDILINQ
10. Tulane University to receive $14M for international HIV/AIDS program
11. International Database Seeks to Boost Treatment of Altitude Sickness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2008)... Conn., July 24 /PRNewswire/ -- People think it,s ...ffer many opportunities to eat right,and stay fit....t menu,selections, so if you order carefully your ...o: http://www.newscom.com/cgi-bin/prnh/20071212/N...mptation, you,ll want to stay,away from the cruise...
(Date:7/24/2008)... Greater access for people with disab...oad on ,Social Security disability system. , ...24, 2008 -- With the signing of the Americans with...n in the lives of people with disabilities and the... gained better access to methods that help them im...
(Date:7/24/2008)... A cleanroom manufacturing company ha...cleanrooms. The feature is a utility panel which ...hance the cleanroom appearance. , ...- Gerbig Engineering, a designer, fabricator and i...t they are now offering a utility panel for integr...
(Date:7/24/2008)... As America's baby boomers age, ...itions such as diabetes that necessitate the use o...t bracelet jewelry gives a generation attractive i...mation. , (PRWEB) July 24...tening health conditions can make a statement in m...
Breaking Medicine News(10 mins):Health News:Actress, Author Mariel Hemingway & Travelers Advantage Say: Treat Yourself To a Healthy Cruise 2Health News:Actress, Author Mariel Hemingway & Travelers Advantage Say: Treat Yourself To a Healthy Cruise 3Health News:Allsup Salutes 18th Anniversary of Americans with Disabilities Act 2Health News:Allsup Salutes 18th Anniversary of Americans with Disabilities Act 3Health News:Gerbig Engineering Announces Availability of Cleanroom Utility Panel 2Health News:Aging Baby Boomers Meld Life-saving Data and Style with Lauren's Hope Fashion Medical ID Bracelet 2Health News:Aging Baby Boomers Meld Life-saving Data and Style with Lauren's Hope Fashion Medical ID Bracelet 3
Life After Death: Organ Donation
...the first study to show that even mildly abnormal ...n elderly men undergoing major surgery," said Dr. ...dical Center and Brown University in Rhode Island....rovidence Veterans Affairs Medical Center and The ...
...s at the University of California, Riverside have ...nces, for two key proteins in the 'dragline silk' ...ad to a variety of new materials for industrial, m...dow spiders dragline silk is a standout compared t...
...-Hajam carefully placed the glass jars over the sl...n to pump out the air. In the ensuing vacuum , the... into the clear containers. "The Assyrians, the C... used to practice cupping to draw out the corrupt ...
Other Medicine News:Health News:Life After Death: Organ Donation 2Health News:Life After Death: Organ Donation 3Health News:Abnormality in the Red Blood Count Cell Poses High Risks 2Health News:Genetic Secrets Behind the Dragline Silk 2Health News:Ancient Healing Technique Gains New Popularity in Iraq 2
(Date:7/22/2008)... Two Regimens Including Lantus(R) and Apidra(R) R...nts with Type 2 Diabetes, Whatever the Algorithm ..., N.J., July 22 /- Results from the "... a Simple Algorithm to Carbohydrate,Counting for A...re,published in the American Diabetes Association,...
(Date:7/22/2008)...est Developed and Validated by Columbia University...s, Proprietary MicroRNA Technology, The Test Dif...ell Lung Cancer (NSCLC), Classifying Squamous-Cel... 96 Percent and Specificity of 90 Percent,This is ...RNAs, Sensitivity as Biomarkers for Accur...
(Date:7/22/2008)... A Pilot Study Suggests That Ekkyo,s New Approach ...tically Improve Scar Healing Physiology, MARSEILL...y known as,Heatwave Technology) a photomedicine co...ystems for skin scar prevention and reduction, ann...le in Lasers in Surgery and Medicine*,reporting th...
(Date:7/21/2008)... LONDON, July 21 /- The SEAS (Simva... investigated the effects of intensive,cholesterol...mg daily) and,ezetimibe (10 mg daily) in patients ...olves partial blockage of the aortic valve in,the ...people in Western,populations. Left untreated, it ...
Breaking Medicine Technology:Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 2Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 4First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 2First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 3First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 4First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 5Ekkyo Describes the First Benefits of Controlled Hyperthermia in Humans in "Lasers in Surgery and Medicine" 2Ekkyo Describes the First Benefits of Controlled Hyperthermia in Humans in "Lasers in Surgery and Medicine" 3Results From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study 2Results From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study 3Results From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study 4Clarient Reports First Quarter 2008 18095 1Clarient Reports First Quarter 2008 18095 2Clarient Reports First Quarter 2008 18095 3Clarient Reports First Quarter 2008 18095 4Clarient Reports First Quarter 2008 18095 5Clarient Reports First Quarter 2008 18095 6Clarient Reports First Quarter 2008 18095 7Clarient Reports First Quarter 2008 18095 8Patient Safety Authority Issues Annual Report for 2007 18091 1Patient Safety Authority Issues Annual Report for 2007 18091 2Patient Safety Authority Issues Annual Report for 2007 18091 3Patient Safety Authority Issues Annual Report for 2007 18091 4Patient Safety Authority Issues Annual Report for 2007 18091 5Patient Safety Authority Issues Annual Report for 2007 18091 6Patient Safety Authority Issues Annual Report for 2007 18091 7Patient Safety Authority Issues Annual Report for 2007 18091 8Patient Safety Authority Issues Annual Report for 2007 18091 9Patient Safety Authority Issues Annual Report for 2007 18091 10Patient Safety Authority Issues Annual Report for 2007 18091 11Patient Safety Authority Issues Annual Report for 2007 18091 12Patient Safety Authority Issues Annual Report for 2007 18091 13Patient Safety Authority Issues Annual Report for 2007 18091 14Patient Safety Authority Issues Annual Report for 2007 18091 15Patient Safety Authority Issues Annual Report for 2007 18091 16Patient Safety Authority Issues Annual Report for 2007 18091 17Patient Safety Authority Issues Annual Report for 2007 18091 18Sigma Aldrich Announces the Integration of Riedel De Haen Into Core Product Brands 5001 1Sigma Aldrich Announces the Integration of Riedel De Haen Into Core Product Brands 5001 2Sigma Aldrich Announces the Integration of Riedel De Haen Into Core Product Brands 5001 3Neurocrine Biosciences Reports First Quarter 2008 Results 1949 1Neurocrine Biosciences Reports First Quarter 2008 Results 1949 2Neurocrine Biosciences Reports First Quarter 2008 Results 1949 3Neurocrine Biosciences Reports First Quarter 2008 Results 1949 4Neurocrine Biosciences Reports First Quarter 2008 Results 1949 5Neurocrine Biosciences Reports First Quarter 2008 Results 1949 6Neurocrine Biosciences Reports First Quarter 2008 Results 1949 7Neurocrine Biosciences Reports First Quarter 2008 Results 1949 8
... - Algeta ASA (OSE: ALGETA), the,Norwegian cancer ...lash;yvind Bruland, of the Norwegian Radium Hospit...ter and Discussion entitled,"Radium-223 in the tr...cancer (HRPC): Results from a randomized,placebo-...ty of,Clinical Oncology,s annual meeting (1-5 June...
...NESS WIRE)--May 29, 2007 - Gilead,Sciences, Inc. (...R-CF1 (CP-AI-007) study of aztreonam lysine for in...ibrosis (CF) who have,pulmonary Pseudomonas aerugi...oint of change at Day 28 from baseline in respirat...uestionnaire-Revised,(CFQ-R), a patient-reported o...
Other Medicine Technology:Algeta to Present Phase II Clinical Study Data for Alpharadin in,Prostate Cancer at ASCO 2Gilead Announces Achievement of Primary Efficacy Endpoint in Second,Phase III Study of Aztreonam Lysine for Inhalation in Patients With,Cystic Fibrosis 2Gilead Announces Achievement of Primary Efficacy Endpoint in Second,Phase III Study of Aztreonam Lysine for Inhalation in Patients With,Cystic Fibrosis 3Gilead Announces Achievement of Primary Efficacy Endpoint in Second,Phase III Study of Aztreonam Lysine for Inhalation in Patients With,Cystic Fibrosis 4Gilead Announces Achievement of Primary Efficacy Endpoint in Second,Phase III Study of Aztreonam Lysine for Inhalation in Patients With,Cystic Fibrosis 5
...nts incorporate a layered design unique in the ind...to prevent stray electrosurgical burns along the s...e or capacitive coupling; a well-documented patien...l AEM Instruments provides a neutral return path f...
...nts incorporate a layered design unique in the ind...to prevent stray electrosurgical burns along the s...e or capacitive coupling; a well-documented patien...l AEM Instruments provides a neutral return path f...
...nts incorporate a layered design unique in the ind...to prevent stray electrosurgical burns along the s...e or capacitive coupling; a well-documented patien...l AEM Instruments provides a neutral return path f...
...nts incorporate a layered design unique in the ind...to prevent stray electrosurgical burns along the s...e or capacitive coupling; a well-documented patien...l AEM Instruments provides a neutral return path f...
Medicine Products: